| ISIN | CH0364960242 |
|---|---|
| Valor Number | 36496024 |
| Bloomberg Global ID | |
| Fund Name | VF (CH) - Valiant Helvétique Balanced VA |
| Fund Provider |
Valiant Bank
Bern, Switzerland Phone: +41 31 320 91 11 Web: www.valiantbank.ch |
| Fund Provider | Valiant Bank |
| Representative in Switzerland |
Lombard Odier Asset Management (Switzerland) SA Bellevue (Geneva) Phone: +41 22 709 21 11 |
| Distributor(s) | Valiant Bank AG |
| Asset Class | Asset Allocation |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | |
| Peculiarities |
| Current Price * | 128.62 CHF | 27.10.2025 |
|---|---|---|
| Previous Price * | 128.60 CHF | 24.10.2025 |
| 52 Week High * | 128.62 CHF | 27.10.2025 |
| 52 Week Low * | 114.58 CHF | 09.04.2025 |
| NAV * | 128.62 CHF | 27.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 573,082,511 | |
| Unit/Share Assets *** | 244,316,635 | |
| Trading Information SIX | ||
| YTD Performance | +8.28% |
31.12.2024 - 27.10.2025
31.12.2024 27.10.2025 |
|---|---|---|
| 1 month | +2.02% |
29.09.2025 - 27.10.2025
29.09.2025 27.10.2025 |
| 3 months | +3.38% |
28.07.2025 - 27.10.2025
28.07.2025 27.10.2025 |
| 6 months | +6.70% |
28.04.2025 - 27.10.2025
28.04.2025 27.10.2025 |
| 1 year | +6.93% |
28.10.2024 - 27.10.2025
28.10.2024 27.10.2025 |
| 2 years | +21.43% |
27.10.2023 - 27.10.2025
27.10.2023 27.10.2025 |
| 3 years | +23.57% |
27.10.2022 - 27.10.2025
27.10.2022 27.10.2025 |
| 5 years | +21.68% |
27.10.2020 - 27.10.2025
27.10.2020 27.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Muzinich Enhancedyield S-T HCHF Acc H | 4.81% | |
|---|---|---|
| UBS Gold Index Fund hCHF I-A acc | 3.99% | |
| AXAWF Euro Credit Total Ret I Cap CHF H | 2.87% | |
| FvS Bond Opportunities CHF IT | 2.84% | |
| Capital Group GlbCorpBd (LUX) Zh-CHF | 2.82% | |
| Novartis AG Registered Shares | 2.58% | |
| UBS Siat | 2.52% | |
| Swiss Rock Emerg Eq/Aktien Schw C | 2.25% | |
| zCapital Swiss Dividend Fund ZA | 2.21% | |
| Roche Holding AG | 2.18% | |
| Last data update | 31.08.2025 | |
| TER *** | 1.26% |
|---|---|
| TER date *** | 31.10.2019 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.66% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |